Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas

Status: open

Preoperative Extended Chemotherapy Vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas

Treatment for Pancreatic Cancer

Contact Us Or call (251) 445-9834

Description

The purpose of this study is to compare any good and bad effects of using chemotherapy compared to chemotherapy and radiation prior to surgery. This study will allow the researchers to know whether which approach is better, the same, or worse than the other.

Sponsors

This trial is sponsored by Alliance for Clinical Trials in Oncology.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.